MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Dermatology

HealthDay 02 July at 04.01 PM

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass

HealthDay 01 July at 03.16 PM

Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue

Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and it

HealthDay 01 July at 03.04 PM

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of

HealthDay 25 June at 09.42 PM

Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus

For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine

HealthDay 24 June at 03.02 PM

Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma

For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random

HealthDay 20 June at 08.56 PM

2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months

From 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil

HealthDay 18 June at 09.11 PM

Approximately 7 Percent of U.S. Population Uninsured in 2023

In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from

HealthDay 18 June at 03.44 PM

Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect

Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive

HealthDay 18 June at 09.50 AM

Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to Expire

In a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h

HealthDay 14 June at 03.32 PM

No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab

There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma &amp; Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub

HealthDay 13 June at 10.58 PM

Health Care Spending Growth Projected to Outpace GDP to 2032

Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare &amp; Medicaid Services in Baltimore, and colleagues projected growth in national health expend

HealthDay 12 June at 03.05 PM

Adverse Effects of Medical Treatment Increasing Worldwide

The burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality &amp; Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences &amp; Peking University Medical Col

HealthDay 07 June at 03.33 PM

Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy

Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen

HealthDay 06 June at 10.28 PM

CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections

Among emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Carl T. Berdahl, M.D., from Cedars-Sinai Medical Center in Los Angeles, and co

HealthDay 05 June at 03.28 PM

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc

HealthDay 03 June at 09.12 PM

9.6 Percent of Medical Visits Took Place Via Telehealth in 2021

In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te

HealthDay 31 May at 03.46 PM

1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema

Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the&nbsp;American Journal of Clinical Dermatology.Lawrence F. Eichenfield, M.D., from the University of California San Diego, and colleagues asse

HealthDay 30 May at 04.04 PM

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b

MedScape 30 May at 07.18 AM

Most Chronic Wounds Not Managed by Dermatologists

"By examining national trends in patient visits and treatment, we may be able to better inform healthcare utilization for cutaneous wounds," Chandy said.

MedScape 30 May at 06.51 AM

Psoriasis Tied to Increased Risk for MACE Despite Statin Use

The finding "highlights the need for further research into tailored treatments for cardiovascular risk in psoriasis patients," Ana Ormaza Vera said.

MedScape 29 May at 11.10 PM

Study Addresses Racial/Ethnic Disparities in Psoriasis Rx

Black patients with psoriasis had the lowest rate of switching to another biologic therapy compared with other racial and ethnic groups, suggesting possible disparities in treatment patterns.

HealthDay 29 May at 09.17 PM

2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending

From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro

MedScape 29 May at 03.36 AM

Dupilumab: Future Treatment for Pediatric Alopecia Areata?

Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia.

MedScape 29 May at 03.07 AM

Tapinarof Cream Effective For AD, Down to Age 2 Years

Results from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.

HealthDay 28 May at 03.08 PM

Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis

Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA Dermatology.Gun Min Youn, from the Stanford University School of Medicine in California, and colleagues conducted a retrospective cross-sectional analysis of the 2014 to

MedScape 27 May at 03.26 AM

Parental e-Cigarette Use May Increase AD Risk in Children

Parental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a retrospective, cross-sectional analysis of US population data.

MedScape 27 May at 02.51 AM

Eczema Risk Increased in Older Adults on Antihypertensives

Use of antihypertensive drugs was associated with a small increase in the rate of eczematous dermatitis diagnoses in older adults, with varying risks with different classes.

HealthDay 24 May at 04.06 PM

Antihypertensives Linked to Eczematous Dermatitis in Seniors

Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine

MedScape 24 May at 06.28 AM

Study Reveals Diverse Skin Manifestations in Hemochromatosis

An iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, can help diagnose hemochromatosis.

MedScape 23 May at 06.32 AM

High-Stage cSCC: Outcomes Superior With Mohs vs WLE

"Our hope is that these findings provide additional data to support Mohs as the standard of care for primary surgical treatment of high-stage cSCC," the study's lead author said.

HealthDay 22 May at 03.50 PM

Global Life Expectancy, Disease Burden Set to Keep Improving

Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a

MedScape 22 May at 11.00 AM

Top Tools for Measuring AD in Clinical Practice Recommended

Consensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds.

MedScape 22 May at 04.53 AM

Home Phototherapy for Psoriasis: Optimizing Access

The ideal candidate "is averse to using systemic agents but whose disease is beyond the point where topical medicines alone will work," Craig A. Elmets, MD, said.

HealthDay 21 May at 10.56 PM

Acrochordons May Be Marker for Metabolic Disease in Children

In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 20

MedScape 20 May at 11.57 PM

Study Finds Radiotherapy for NMSC in Dermatology Growing

There is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists.

HealthDay 20 May at 03.58 PM

Individuals With BAP1 Have High Rate of Nail Abnormalities

Individuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.Alexandra Lebensohn, from the Nat

MedScape 20 May at 03.03 AM

Chart Review Highlights Unique AD Features in Older Patients

More research is "needed to elucidate the unique features of elderly AD in pathophysiology and optimal treatments," the study authors wrote.

MedScape 19 May at 11.07 PM

Study Identifies Several Onychomycosis Risk Factors

Tinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in patients with onychodystrophy.

MedScape 16 May at 09.26 AM

Skin Tags Linked to Metabolic Syndrome in Children

Acrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases.

MedScape 16 May at 09.23 AM

Wits of Pediatric Dermatologists Pitted Against ChatGPT

Overall, version 4.0 of the AI tool performed better than version 3.5.

MedScape 16 May at 05.10 AM

Tranexamic Acid Injection Reduces Bleeding After Mohs

Adverse effects associated with using the antifibrinolytic were rare.

HealthDay 15 May at 07.29 PM

Non-Hispanic Black Melanoma Patients Present With Advanced Disease

Non-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study published in the May issue of the Journal of Surgical Oncology.Jessica A. Steadman, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined fe

HealthDay 15 May at 03.45 PM

AACR Delivers Report on Disparities in Cancer Progress

In its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un

MedScape 14 May at 10.13 AM

US Study Delves Into Risk Factors for Melasma

Exposure to hormones, hyperpigmenting drugs, and multiparity increased risk for melasma across different racial groups in a US study of a diverse population.

HealthDay 13 May at 10.34 PM

Physicians With Disabilities May Experience Depersonalization

Physicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in&nbsp;JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb

HealthDay 13 May at 03.50 PM

Study Identifies Factors Associated With Hydroxychloroquine Retinopathy

Factors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or greater, according to a study published online May 9 in JAMA Network Open.April M. Jorge, M.D., from Massachusetts General Hospital in Boston, and colleagues identified

HealthDay 13 May at 03.46 PM

Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights

Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment, according to a study published online April 17 in the Journal of Personalized Medicine.Georgiana Strugariu, from "Grigore T. Popa" University of Medicine and Phar

MedScape 13 May at 09.58 AM

Patient Preferences Drive Treatment Options for Early HS

Most ongoing trials of HS treatments are for moderate to severe disease, Dr Jennifer L. Hsiao said.

MedScape 13 May at 08.59 AM

Reimbursement Rates for Mohs Surgery Lag Behind Inflation

Healthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates.

MedScape 13 May at 07.29 AM

Experts Share Practical Tips for Diagnosing Mild HS

"Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections," Sayed said.

MedScape 13 May at 06.18 AM

Kids With Skin Diseases Face Stigma, Reduced Quality of Life

Physicians' assessment of disease severity and visibility may underestimate the disease's effects on the patient, data suggested.

HealthDay 10 May at 12.42 PM

Cyberattack Cripples Major U.S. Health Care Network

Ascension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid

MedScape 10 May at 06.19 AM

Immunosuppression Risk Factor for Poor cSCC Outcomes

In contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes.

MedScape 09 May at 08.55 AM

Adalimumab Improves Blood Parameters in Patients With HS

Treatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders.

MedScape 09 May at 08.47 AM

SDM in Pediatric Dermatology: Step Approach Recommended

A pediatric dermatologist proposes a four-step approach to using shared decision-making (SDM) when caring for children and adolescent patients with acne and other skin conditions.

MedScape 09 May at 06.33 AM

Evidence Accumulating on Viral Cause of Cutaneous Granulomas

Of the cases accruing in the United States and elsewhere, most but not all were linked to inborn errors of immunity.

HealthDay 08 May at 03.29 PM

Trifarotene Plus Skin Care Beneficial for Acne Vulgaris

Trifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medical College in New York City, and colleagues conducted a phase IV

HealthDay 08 May at 03.07 PM

Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk

Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the&nbsp;Journal of Allergy and Clinical Immunology.Courtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues e

MedScape 08 May at 04.39 AM

IPC Develops Consensus on Generalized Pustular Psoriasis

The IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical considerations to speed treatment of this potentially life-threatening condition.

MedScape 07 May at 08.28 AM

Many Drugs Linked to Pediatric SJS-TEN, WHO Data Show

Antiepileptic and anti-infectious agents were the most common classes tied to SJS-TEN.

MedScape 07 May at 05.02 AM

Some Patients More Likely to Get Opioids After Mohs Surgery

Certain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use.

MedScape 07 May at 04.19 AM

Rates of Emotional and Physical Stress High in Mohs Surgeons

Almost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury.

MedScape 06 May at 03.58 AM

Correct Dx of Cancer Treatment Skin Effects Evaluated

The survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions.

MedScape 06 May at 03.35 AM

Review Addresses Skin Manifestations of Cystic Fibrosis

A review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF.

MedScape 06 May at 12.01 AM

Many Patients With Advanced MCC Not Receiving Immunotherapy

Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.

HealthDay 02 May at 03.37 PM

Algorithm From EHR Can ID Common Variable Immunodeficiency Disease

A machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and tre

MedScape 02 May at 07.17 AM

Mpox Presentation Compared in Racial, Ethnic Groups

A retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color.

MedScape 02 May at 07.10 AM

ILD Not Increased With MTX in Patients With Dermatomyositis

Treatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis.

HealthDay 30 April at 04.12 PM

Stigma Affects Quality of Life in Children With Chronic Skin Conditions

Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and col

MedScape 30 April at 09.07 AM

Heat-Based Wrinkle Treatment Holds up With Facial Anesthesia

Surface anesthesia prior to thermomechanical fractional injury therapy for wrinkles around the eyes provided adequate comfort, with positive treatment outcomes, a small study found.

MedScape 30 April at 03.39 AM

Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review

A decision on approval is expected in the fourth quarter of 2024.

MedScape 29 April at 05.54 AM

Children With Chronic Skin Disorders Face Substantial Stigma

Healthcare professionals should be aware of the possibility of stigmatization and bullying when assessing the social and mental health of children and adolescents with chronic skin disorders.

MedScape 26 April at 07.49 AM

Prurigo Nodularis Associated With Elevated CV Risks

"The potential risk of subsequent cardiovascular disease should be considered in the care of patients with PN," according to the study authors.

MedScape 25 April at 09.28 AM

FDA Seeks More Information About RDEB Rx Under Review

Pz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds.

HealthDay 24 April at 07.53 PM

Tobacco Smoking Reduces the Odds of Psoriasis Improvement

Tobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The

MedScape 24 April at 03.16 AM

Erenumab Reduces Flushing and Erythema in Rosacea

A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.

HealthDay 23 April at 03.53 PM

Atopic Dermatitis Negatively Impacts Mental Health

Atopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in&nbsp;Dermatitis.Jessica K. Johnson, M.P.H., from the National Eczema Association in San Rafael, California, and colleagues evaluated patient-reported MH symptoms and their c

MedScape 22 April at 08.32 AM

Hair Loss: Experts Provide Recommendations on Oral Minoxidil

The authors "identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients."

MedScape 22 April at 06.12 AM

Neuromodulators: Rapid-Onset Option, Other Emerging Trends

Expect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says.

MedScape 22 April at 03.32 AM

Study Shows Faster Recovery, Less Pain With 2910-nm Laser

A small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers.

MedScape 22 April at 03.22 AM

Does AD Severity Affect Growth in Children?

An analysis evaluated growth in a study of 1326 children with AD younger than 12 years.

HealthDay 19 April at 03.41 PM

Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome

Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.Xiang Li Tan, M.B.B.S., from St. George's University Hospitals NHS Foundation Trust in London, and colleagues conducted a systematic review to examine the prevalence, types, and prognos

MedScape 19 April at 08.52 AM

Less PIH After Modified Laser Rx for Lentigines Reported

A 532-nm picosecond laser with fractional-beam microlens array to treat solar lentigines resulted in a lower hyperpigmentation rate in patients with darker skin types, vs the full-beam approach.

MedScape 19 April at 04.58 AM

Registry Gives Snapshot of Cosmetic Procedure-Related AEs

A registry of adverse events from dermatologic procedures found that blistering, hypopigmentation, scars, and burns are the most common complications from laser and energy devices.

MedScape 18 April at 06.44 AM

Laser, Light Treatments Effective for PCOS-Related Hirsutism

Laser and light hair treatments, with and without other treatments, improve hirsutism and related psychological measures in women with PCOS.

MedScape 18 April at 02.59 AM

Weekly Laser Treatment Promising for Port-Wine Birthmarks

Once-weekly PDL treatment in infants led to near-total or total clearance of PWB and was well-tolerated in 10 infants, suggesting further investigation of the reduced treatment interval of 1 week.

HealthDay 17 April at 04.00 PM

Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing

The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA Dermatology.Nita K.F. Wienholtz, M.D., Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleag

MedScape 17 April at 09.37 AM

Study Evaluates Time of Lung Disease Onset With Rare DM

Rapidly progressive interstitial lung disease was diagnosed in almost half of the patients with MDA5 antibody-positive dermatomyositis.

MedScape 16 April at 02.08 PM

CDC Investigating Reactions Linked to Counterfeit 'Botox'

Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism.

HealthDay 16 April at 11.40 AM

CDC Warns of 19 Cases of Botched Botox Shots in 9 States

Counterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the U.S. Centers for Disease Control and Prevention said nine people had been hospitalized and four we

MedScape 16 April at 06.17 AM

Survey Highlights Impact of Cosmetic-Procedure Complications

Study finds that people who have complications after cosmetic procedures have higher rates of depression, anxiety, and other mental health issues than before the procedures.

MedScape 16 April at 06.05 AM

Counterfeit Neurotoxin Investigations Prompt Call for Action

The American Society for Dermatologic Surgery Association emphasized the risks for medical procedures in unlicensed settings.

MedScape 16 April at 05.35 AM

Review Evaluates Data on Injectables in Skin of Color

In this literature review, researchers found that neuromodulators and dermal fillers are useful and safe in SOC populations, although more data are needed in some groups.

MedScape 15 April at 08.49 AM

Survey Highlights Benefits of Pediatric Derm-Rheum Clinics

Pediatric dermatology-rheumatology combined clinics improve patient outcomes and satisfaction.

MedScape 15 April at 02.03 AM

Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors

Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.

MedScape 15 April at 01.34 AM

Alopecia Areata: Late Responses to JAK Inhibitors Reported

Response curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting.

MedScape 12 April at 09.42 AM

Extension Data Reported for Chronic Hand Eczema Treatment

Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.

MedScape 12 April at 08.58 AM

Topical Vs Oral Minoxidil for AGA: Which Is More Effective?

Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil.

MedScape 12 April at 08.25 AM

What's Behind Long-Term Antibiotic Prescribing for Acne?

"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview.

HealthDay 10 April at 06.15 PM

Study Identifies Factors That Affect Antibiotic Prescribing for Acne

Multiple salient factors affect long-term antibiotic prescribing practices for acne, according to a study published online April 3 in JAMA Dermatology.Ronnie A. Festok, from the Emory University School of Medicine in Atlanta, and colleagues conducted a qualitative study assessing data collected from stakeholders (dermatologists, inf

HealthDay 10 April at 03.57 PM

Bioactive Retinol Efficacious for Improving Signs of Photoaging

Stabilized bioactive retinol is efficacious for improving signs of photoaging, without causing major irritation, according to a study published in the April issue of the Journal of Drugs in Dermatology.Patricia Farris, M.D., from Tulane University School of Medicine in New Orleans, and colleagues examined the comprehensive efficacy

MedScape 10 April at 07.46 AM

New Tool Could Help Screen Patients for Zoom Dysmorphia

Individuals with zoom dysmorphia tend to scrutinize their facial features and fixate on what they think needs to improve and feel pressured to appear perfect before virtual meetings.

MedScape 10 April at 05.22 AM

Childhood Atopic Dermatitis Linked to IBD Risk

A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.

MedScape 09 April at 03.18 AM

Expert Recommends Phased Approach For Delusional Infestation

Phase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life.

MedScape 09 April at 12.35 AM

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.

HealthDay 08 April at 10.30 PM

FDA Approves New Antibiotic for Three Indications

The U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream infections, adults with acute bacterial skin and skin structure infections, and adult and pediatric patients (age 3 months

MedScape 05 April at 08.16 AM

Transplant Recipients: Consider Skin Cancer, Infection Risks

Recent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients.

MedScape 05 April at 03.22 AM

Medicare IHC Claims With Melanoma Dxs Increased, Study Finds

With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.

MedScape 05 April at 02.17 AM

FDA Accepts Application for a New HS Treatment

Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

MedScape 04 April at 06.39 AM

Review Describes Semaglutide-Associated Skin Effects

Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.

HealthDay 03 April at 03.45 PM

Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma

Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.Lauren Banner, from Thomas Jefferson University in Philadelphia, and colleagues used the Surveillance, Epidemiolo

MedScape 03 April at 06.01 AM

Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus Trial

Rilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus.

MedScape 03 April at 03.29 AM

Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

MedScape 03 April at 02.33 AM

Intralesional Wart Treatments Are Among Options to Consider

Alternatives to SA and cryotherapy for warts may be helpful "for patients who have failed traditional therapies or have a contraindication to the usual go-tos," said Dr Jennifer Adams.

MedScape 02 April at 07.41 AM

JAK Inhibitors for Vitiligo: More Skin Response Over Time

Two JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib.

MedScape 01 April at 01.39 AM

Tooth Enamel Disorder Is a Feature of Kindler EB

Study found that hypoplastic pitted amelogenesis imperfecta is among the oral manifestations of Kindler epidermolysis bullosa, underscoring the need for early and sustained dental care.

MedScape 01 April at 01.16 AM

Rate of Malignancy Low in Pediatric LM

Pediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy.

HealthDay 29 March at 03.14 PM

U.S. Doctors Received Industry Payments of $12.13 Billion From 2013 to 2022

U.S. physicians received $12.13 billion from industry from 2013 to 2022, according to a research letter published online March 28 in the Journal of the American Medical Association.Ahmed Sayed, M.B.B.S., from Ain Shams University in Cairo, and colleagues examined the distribution of payments within and across specialties and the medica

HealthDay 29 March at 11.42 AM

High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA Warns

Some pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided, the U.S. Food and Drug Administration warns.These creams, gels, sprays and soaps are marketed for topical use to relieve the pain of cosmetic procedures like microdermabrasion, laser hair removal, tattooing and <a href="http

MedScape 27 March at 12.24 PM

FDA Warns Consumers Against Using Some Topical Analgesics

The warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures.

MedScape 26 March at 06.37 AM

Hair-Straightening Products Entail Acute Kidney Failure Risk

Products containing glyoxylic acid were associated with the accumulation of calcium oxalate crystals in the kidneys.

HealthDay 25 March at 03.55 PM

Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic Procedures

Time spent on social media and use of photo-editing applications contribute to the desire to undergo a cosmetic procedure, according to a study recently published in the&nbsp;Journal of Clinical and Aesthetic Dermatology.Iman F. Khan, M.D., M.P.H., from Boston University, and colleagues surveyed 175 adults visiting an outpatient dermat

HealthDay 22 March at 10.09 PM

Four in 10 Adults Choose Telemedicine Visits

Many patients, including those with the greatest care needs, choose telemedicine even when in-person visits are available, according to a study published online March 22 in&nbsp;JAMA Network Open.Eva Chang, Ph.D., M.P.H., from Advocate Health in Milwaukee, Wisconsin, and colleagues assessed patient characteristics associated with telem

HealthDay 22 March at 03.58 PM

Survey Assesses Perspectives on Patient Image Use in Dermatology

Most patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research letter published online March 13 in JAMA Dermatology.Trina Salvador, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a s

HealthDay 22 March at 03.56 PM

Physicians Concerned About Private Equity's Impact on Health Care

Physicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in&nbsp;JAMA Internal Medicine.Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views towa

MedScape 22 March at 01.58 AM

Acne Products With Benzoyl Peroxide Under Scrutiny

In a citizen's petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate.

HealthDay 21 March at 10.59 PM

Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022

Life expectancy increased to 77.5 years in 2022, while the age-adjusted rate of drug overdose deaths increased from 2002 to 2022 but did not change from 2021 to 2022, according to two March data briefs published by the National Center for Health Statistics.Kenneth D. Kochanek, from the National Center for Health Statistics in Hyattsville, Mar

MedScape 21 March at 09.16 AM

AI in Dermatology: Consider Its Limitations and Problems

Artificial intelligence is coming to clinical dermatology, but its enormous promise for improving the lives of patients and physicians will depend on addressing the expected problems.

MedScape 21 March at 07.58 AM

Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy

A study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine.

MedScape 20 March at 01.03 PM

Study Evaluates Acne Risk With Reversible Contraception

In the study, 28.5% of the adolescents and young adults experienced worsening acne after insertion of a progestin-only long-acting reversible contraceptive, and 17% reported acne as a new concern.

MedScape 20 March at 07.14 AM

FDA Expands Approval of Treatment for GPP

Spesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.

HealthDay 19 March at 11.05 PM

American Academy of Dermatology, March 8 to 12

The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in dermatology. The conference highlighted recent advances in the diagnosis and management of d

HealthDay 19 March at 03.42 PM

AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia

For adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Brett King, M.D., Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues reported po

MedScape 19 March at 07.48 AM

Roflumilast Cream Quickly Improved AD in Children, Ages 2-5

Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of "clear" or "almost clear" plus a two-grade improvement from baseline at week 4.

HealthDay 18 March at 03.55 PM

AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis

Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medicine in New York Ci

HealthDay 18 March at 03.52 PM

AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia

MONDAY, March 18, 2024 (HealthDay News) --&nbsp;Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Rodney D. Sinclair, M.D., from the University of Me

MedScape 18 March at 05.46 AM

Tips on Managing Acne in Transmasculine Patients

Testosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said.

HealthDay 15 March at 03.25 PM

AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air Pollution

Short-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Alex Ha, from the University of California, San Francisco, and colleagues conducte

HealthDay 15 March at 03.21 PM

AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis

FRIDAY, March 15, 2024 (HealthDay News) --&nbsp;Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Bruce Strober, M.D., Ph.D., from the Yale Sc

MedScape 15 March at 11.40 AM

Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks

The encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis.

MedScape 15 March at 05.49 AM

Most Baby Cleansers Are Not 'Allergen-Free,' Study Finds

A recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims.

HealthDay 14 March at 12.04 PM

HHS Opens Investigation Into UnitedHealth Cyberattack

Following a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said Wednesday it has begun an investigation into the incident.In a&nbsp;<a href="https://www.hhs.gov/about/news/2024/03/13/h

MedScape 14 March at 09.07 AM

Major Responses Seen for Cicatricial and Total Hair Loss

Two oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology.

MedScape 14 March at 06.42 AM

Florida Bill Addresses Coverage of Skin Cancer Screening

Some 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis.

HealthDay 13 March at 12.05 PM

Cyberattack Leaves Health Care Providers Reeling Weeks Later

Following a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day.That <a href="https://www.ama-assn.org/press-center/press-releases/cyberattack-jeopardizes

MedScape 13 March at 07.06 AM

2024 AAD Acne Guidelines: Newer Therapies Join Old Standbys

A coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news.

HealthDay 12 March at 10.49 PM

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties

Pediatric atopic dermatitis (AD) is&nbsp;associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study published online March 6 in&nbsp;JAMA Dermatology.Emily Z. Ma, from the University of Maryland School of Medicine

MedScape 12 March at 04.54 PM

Lebrikizumab Found Effective for Patients With AD, SOC

Interim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI.

MedScape 11 March at 05.36 PM

Study Eyes Effect of Maternal HS on Outcomes in Offspring

The study population included nearly 1.3 million children born in Quebec, Canada, over a 16-year period.

MedScape 10 March at 07.53 PM

Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control

Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.

MedScape 10 March at 05.01 PM

Home- and Office-Based Phototherapy for Psoriasis Compared

The multicenter LITE trial included 783 patients at 42 sites in the United States.

MedScape 10 March at 02.29 PM

During Pregnancy, Many Drugs Safe for Skin Infections

Several drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues.

MedScape 09 March at 04.07 PM

New NCCN Melanoma Guidelines Capture Evolving Best Practice

NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.

MedScape 09 March at 02.41 PM

Novel Drug Shows Promise for Hidradenitis Suppurativa

The findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS.

MedScape 08 March at 06.28 PM

Flexibility Advised for Patients With Personality Disorders

Up to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD.

HealthDay 08 March at 04.59 PM

AAD: Concerns Noted Relating to Use of AI Dermatology Apps

There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Shannon Wongvibulsin

MedScape 08 March at 04.07 PM

Anti-DEI Petition Sparks Conflict at Nat'l Derm Meeting

A controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group's annual meeting starting today.

MedScape 08 March at 08.01 AM

Sulfites Selected as ACDS Allergen of the Year

Experts lobby for increased inclusion of sulfites in patch test panels.

MedScape 08 March at 06.14 AM

Psoriasis Study Shows a Path for Considering US Drug Costs

Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.

HealthDay 07 March at 02.00 PM

Carcinogen Benzene Can Form in Some Acne Treatments: Report

Some acne treatments may banish blemishes but carry hidden dangers: A new report reveals high levels of the carcinogen benzene can form in products that contain the zit-fighting ingredient benzoyl peroxide.According to the new&nbsp;report from

MedScape 07 March at 07.06 AM

Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?

The analysis included children aged 17 years or younger without intellectual disability or autism.

HealthDay 06 March at 04.38 PM

Skin of Color Underrepresented in AI Programs in Dermatology

Challenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets, according to research published online March 6 in the International Journal of Dermatology.Rebecca Fliorent, from the Rowan-Virtua School of Osteopathic Medicine in St

MedScape 06 March at 01.53 AM

New Indication Approved for Juvéderm

In a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response.

HealthDay 06 March at 12.00 AM

Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis

For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt in Germany, and colleagues conducted a multicenter, double-blind, vehicle-controlled phase 3 trial to examine the e

HealthDay 06 March at 12.00 AM

Higher Use of Health Care Portal Seen During COVID-19 Pandemic

Health care portal use was higher during the COVID-19 pandemic, according to a study published online Feb. 29 in JAMA Network Open.Esther Yoon, Ph.D., M.P.H., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined the prevalence of health care portal use before, during, and after the most re

MedScape 04 March at 10.21 PM

FDA Approves Another Neurotoxin for Frown Lines

The product has been sold in more than 50 countries, the company says.

MedScape 03 March at 11.01 PM

Patient-Reported Outcomes Important in Cutaneous GVHD: Study

The study results "highlight the importance of patient-reported outcomes in measuring this disease," the study's lead author said.

MedScape 01 March at 02.06 AM

Review Highlights Evidence of Climate Change Effects on AD

Atopic dermatitis "could serve as a case study for climatic impacts on health," the authors emphasized in their paper.

MedScape 29 February at 11.18 PM

Study Finds No Increased Cancer Risk With Spironolactone

Over 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone.

MedScape 29 February at 12.45 AM

What’s The Incidence Rate of a Second Primary Melanoma?

The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said.

HealthDay 27 February at 04.59 PM

Delayed Melanoma Care During Pandemic Proved Costly

Delays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in&nbsp;JAMA Network Open.Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associa

MedScape 27 February at 07.38 AM

What Drives Fatigue in Psoriasis and PsA?

Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.

HealthDay 26 February at 05.02 PM

Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic

During the COVID-19 pandemic, cancer diagnoses were lower than expected, according to a study published online Feb. 22 in JAMA Oncology.Todd Burus, from the Markey Cancer Center at the University of Kentucky in Lexington, and colleagues conducted a population-based cross-sectional analysis of cancer incidence trends using data on cases

MedScape 26 February at 01.47 AM

TikTok Info on Infantile Hemangiomas Suspect: Study

In a cross-sectional study of the social media platform, researchers analyzed 50 videos on the topic.

MedScape 26 February at 12.34 AM

Biologic Treatment for Psoriasis Linked to Lower Mortality

Evidence to support the hypothesis that the use of systemic immunomodulatory agents for psoriasis "quenches systemic inflammation and potentially improves" survival is limited, investigators said.

HealthDay 23 February at 11.30 PM

Level of Burnout Higher for Women in Health Care Occupations

Women in health care occupations endure a significantly higher level of stress and burnout than men, according to a study published online Feb. 21 in Global Advances in Integrative Medicine and Health.Viktoriya Karakcheyeva, M.D., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colle

MedScape 23 February at 12.38 PM

EMA Approves Tx for Psoriasis and Other Autoimmune Disorders

The biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009.

MedScape 23 February at 09.00 AM

'Superclinic' Powers Through Skin Cancer Referrals

One hospital's experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery.

MedScape 23 February at 01.34 AM

Longer IV Ertapenem Course Beneficial for Recalcitrant HS

2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning.

HealthDay 22 February at 12.17 PM

Jill Biden Announces $100 Million for Research on Women's Health

First Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We will build a health care system that puts women and their lived experiences at its center,” Biden said in a White House <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/02/21/remarks-as-prepared-for-deliv

MedScape 22 February at 08.13 AM

One-a-Day Pill for Alopecia Recommended for NHS Use

NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.

HealthDay 21 February at 04.01 PM

Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa

Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.Avigdor Nosrati, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a retrospective rev

HealthDay 21 February at 01.45 PM

This Election Year, Health Care Costs Top Voter Concerns: Poll

Unexpected medical bills and high health care costs are dominating an election where kitchen table economic problems weigh heavily on voter’s minds, a new KFF poll has found.Voters struggling to pay their monthly bills are most eager to hear presidential candidates talk about economic and health care issues, according to the latest KFF Health

MedScape 21 February at 02.12 AM

Nemolizumab Being Reviewed for AD, Prurigo Nodularis

For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.

MedScape 20 February at 10.49 PM

What Skin Manifestations Are Associated With Pediatric IBD?

Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common.

HealthDay 20 February at 04.26 PM

Amtagvi Approved by the FDA for Treatment of Advanced Melanoma

Amtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer."The approval of Amtagvi offers hope to those with advanced melanoma who have progressed following initial standard-of-care therapies

HealthDay 17 February at 12.00 AM

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA

The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other anaphylaxis rescue remedies, the agency stressed. Instead, "Xolair is intended for repeated use to reduce the risk of allergic re

HealthDay 16 February at 04.32 PM

Deep Learning Improves Diagnostic Accuracy for Skin Diseases

Deep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatol

MedScape 16 February at 12.53 AM

Cellulite: Outcomes 1 Year After Noninvasive Treatment

The findings build on results from a 12-week study of the device, which the investigators said "induces physical shearing of fibrous septa through rapid acoustic pulses."

MedScape 16 February at 12.02 AM

Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.

HealthDay 15 February at 04.42 PM

FDA Approves Aurlumyn for Severe Frostbite

Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation."This approval provides patients with the first-ever treatment option for severe frostbite," Norman Stockbridge, M.D., director of the Division of Cardiol

HealthDay 14 February at 11.06 PM

Study Looks at Access to U.S. Burn Centers Using 2019 Data

Access disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified a

MedScape 14 February at 02.14 AM

Lab Testing in Patients on Immunomodulators Falls Short

Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.

MedScape 13 February at 11.11 PM

Tinea Capitis Management in Kids Varies, Survey Finds

Respondents included 56 members of the Pediatric Dermatology Research Alliance.

HealthDay 12 February at 04.17 PM

Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies

The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospectiv

HealthDay 12 February at 04.13 PM

Smoking Linked to Melanoma-Associated Death in Early-Stage Melanoma

For patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 in JAMA Network Open.Katherine M. Jackson, M.D., from the Saint John's Cancer Institute at Providence Saint John's Health Center in Santa Monica, California, and col

MedScape 09 February at 05.04 PM

Tools on the Horizon for Managing Posttransplant cSCC Risk

Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients.

HealthDay 09 February at 04.56 PM

Health Care Costs, Resource Utilization Increased for Vitiligo Patients

Patients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of Investigative Dermatology.Khaled Ezzedine, M.D., from Henri Mondor University Hospital in Créteil,&nbsp;France, and colleagues conducted a retrospective cohort analysis

MedScape 09 February at 04.42 PM

Analysis Finds Allergens in Many Topical Scar Products

Of the 156 products identified, most were gels, creams, or oils.

MedScape 09 February at 05.44 AM

Spitz Nevi: An Expert Shares Tips for Diagnosis, Management

Dr Caroline Piggott provides her perspective on dermoscopy, shave vs punch biopsies, and treatment.

MedScape 09 February at 02.26 AM

Periocular Melanoma Still Rare, But May Be Increasing

Pain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants.

MedScape 09 February at 12.38 AM

Study Shows Disparities in Diagnosing Across Skin Tones

Across all images, diseases in darker skin types were diagnosed less accurately than diseases in lighter skin types, including when decision support from a deep learning system was introduced.

HealthDay 08 February at 04.39 PM

JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis

For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England Journal of Medicine.Robert Bissonnette, M.D., from Innovaderm Research in Montreal, and colleagues conducted a phas

MedScape 07 February at 11.18 PM

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million

The most expensive gene therapy on the US market may give payers pause, said study authors.

MedScape 07 February at 05.09 PM

Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis

The small-molecule oral investigational agent JNJ-77242113 at the highest dose tested was associated with reductions in psoriasis severity comparable to injectable biologic agents.

MedScape 07 February at 06.09 AM

AAD Updates Acne Management Guidelines

The new guidelines updated the AAD's 2016 guidelines and included 18 recommendations and five good practice statements.

MedScape 06 February at 01.46 AM

Dupilumab Improves AD Affecting the Hands, Feet

Dupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis.

MedScape 06 February at 01.37 AM

MACE, VTE Risks Not Increased With JAK inhibitors: Study

In studies with an average follow-up of 16 weeks, there was no significant increase in MACE or VTE rates in people with dermatoses treated with JAK-STAT inhibitors.

HealthDay 05 February at 11.45 PM

Price of Prescription Drugs Almost Threefold Higher in the United States

Prescription drug prices are nearly three times higher in the United States than in other countries, according to a report published by the RAND Corporation.Andrew W. Mulcahy, and colleagues from the RAND Corporation, compared the prices of different categories of drug products, including brand-name originator drugs, unbranded generic drugs, biol

HealthDay 05 February at 04.29 PM

AAD Updates Guidelines for Management of Acne Vulgaris

In guidelines issued by the American Academy of Dermatology and published online Jan. 30 in the Journal of the American Academy of Dermatology, updated recommendations are presented for the management of acne vulgaris.Rachel V. Reynolds, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a systematic revi

HealthDay 02 February at 03.50 PM

Gender Minority Adults Are Vulnerable During Full Body Skin Exam

Within the sexual and gender minority (SGM) population, gender minority adults are more likely to report discomfort during full body skin examinations (FBSEs), according to a research letter published online Jan. 31 in JAMA Dermatology.Michelle Verghese, from the Pritzker School of Medicine at the University of Chicago, and colleagues us

MedScape 01 February at 02.06 AM

Rosacea and Recent Research Back Potential New Therapies

What do botulinum toxin, paroxetine, and a low-molecular-weight heparan sulfate analog have in common? Each has evidence as a potential treatment for people with rosacea.

MedScape 31 January at 11.32 PM

Successful Acne Scar Treatment Can Boost Quality of Life

The three main types of acne scars can dictate the approach to treatment.

HealthDay 29 January at 10.54 PM

Practitioner Empathy Interventions Can Improve Patient Satisfaction

Health care practitioner empathy interventions seem to improve patient satisfaction, but inadequate reporting hinders the ability to draw definitive conclusions relating to the overall effect size, according to a review published online Jan. 30 in the Annals of Internal Medicine.Leila Keshtkar, Ph.D., from the University of Leicester in

HealthDay 29 January at 04.10 PM

Early FDG PET/CT Can ID Metabolic Changes in Advanced Melanoma

For patients with advanced melanoma, early 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging can identify metabolic changes that may predict response to pembrolizumab, according to a study published online Jan. 24 in Clinical Cancer Research.Thomas M. Anderson, M.D., from the Per

HealthDay 25 January at 10.58 PM

2004 to 2019 Saw Increase in Isotretinoin Use in Girls, Women

From 2004 to 2019, there was an increase in isotretinoin use among girls and women of childbearing age in Germany, according to a study published online Jan. 25 in PLOS Medicine.Jonas Reinold, from the Leibniz Institute for Prevention Research and Epidemiology–BIPS in Bremen, Germany, and colleagues determined the age-standardized pre

MedScape 25 January at 10.59 AM

Think Outside the Traditional Toolbox to Treat Itch

Naloxone and strontium are just a few of the "out of the box" therapies dermatologists can consider for treating chronic itch.

MedScape 25 January at 06.42 AM

Emerging Therapies Foretell New Era for Cutaneous Disorders

Analogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders.

HealthDay 24 January at 04.55 PM

Climatic Hazards Linked to Aggravation of Atopic Dermatitis

Climatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in Allergy.Sheng-Pei Wang, M.D., M.P.H., from the University of California San Francisco, and colleagues identified 18 studies with evidence for an impact of AD by leve

MedScape 24 January at 11.00 AM

How Does Rituximab for Pemphigus Fare in the Long Term?

This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent.

HealthDay 23 January at 04.18 PM

Apremilast May Offer Cardiometabolic Benefit in Psoriasis Patients

For patients with moderate-to-severe psoriasis, apremilast appears to have a neutral association with aortic vascular inflammation, generally beneficial associations with certain cardiometabolic biomarkers, and associations with reductions in visceral and subcutaneous fat, according to a study published online Sept. 21 in JAMA Dermatology.

MedScape 23 January at 10.26 AM

Study Finds Multidisciplinary Pediatric AD Clinic Beneficial

The clinic is a collaborative effort between Rady Children's Hospital and the University of California San Diego Health Divisions of Dermatology, Allergy & Immunology, and the hospital's pharmacy.

MedScape 23 January at 03.49 AM

Hair Creams: Do You Know the Health Risks?

Some products may be easy on the hair but hard on the eyes.

HealthDay 22 January at 10.13 PM

Older Adults Average 20.7 Total Health Care Contact Days a Year

Older adults have a mean of 20.7 total health care contact days per year, according to a study published online Jan. 23 in the Annals of Internal Medicine.Ishani Ganguli, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues characterized health care contact days among community-dwelling adults aged 65 years and olde

MedScape 22 January at 08.46 AM

Diet and Skin: What is the Evidence?

There are scientific studies linking dietary factors to acne, atopic dermatitis, rosacea, and other common skin conditions.

MedScape 22 January at 02.44 AM

Hair Loss in Children: How to Dx and Treat Different Causes

Topical and systemic treatments can help children and teens regrow hair and reduce anxiety and bullying.

HealthDay 20 January at 12.01 AM

Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure

Prenatal opioid exposure (POE) is associated with an increased risk for infection, eczema and dermatitis, and asthma in offspring, but it is not linked to allergies or anaphylaxis, according to a study published online Jan. 17 in JAMA Network Open.Erin Kelty, Ph.D., from the University of Western Australia in Crawley, and colleagues com

HealthDay 19 January at 05.24 PM

Bidirectional Link ID'd for Autoimmune Disease, Perinatal Depression

There is a bidirectional association between autoimmune disease (AD) and perinatal depression (PND), according to a study published online Jan. 9 in Molecular Psychiatry.Emma Bränn, from the Karolinska Institutet in Stockholm, and colleagues examined the bidirectional association between PND and AD using nationwide Swedish population an

MedScape 19 January at 04.30 AM

Smoking Associated With Risk for Hair Loss Among Men

The risk for progression of androgenetic alopecia is higher among those who smoke as well, according to an analysis.

MedScape 18 January at 03.57 AM

New Molecules Reflect Advances in Atopic Dermatitis

Topical formulations of JAK inhibitors could help treat moderate to severe atopic dermatitis in adults and adolescents, said one dermatologist.

MedScape 17 January at 05.41 PM

AI-Powered Device Cleared as Noninvasive Skin Cancer Test

The handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds.

HealthDay 17 January at 04.58 PM

Inflammation, Poverty Have Synergistic Effect on Mortality

There is a potential synergistic effect for inflammation and living in poverty with increased mortality risk for adults, according to a study published online Jan. 16 in Frontiers in Medicine.Arch G. Mainous III, Ph.D., from the University of Florida in Gainesville, and colleagues examined whether there is a synergistic effect of the

HealthDay 17 January at 04.55 PM

Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa

Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, according to a study published online Jan. 10 in JAMA Dermatology.Nicole Salame, M.D., from the Emory Un

MedScape 17 January at 07.38 AM

Review Spotlights Effects of Epidermolysis Bullosa on Bones

Researchers summarized recommendations from 13 published studies.

MedScape 15 January at 05.32 AM

Study Estimates Post-COVID Risk for Alopecia Areata

The incidence of alopecia areata in patients with COVID-19 was significantly higher than that in the uninfected controls, in a large Korean cohort study.

MedScape 15 January at 02.14 AM

How Should Dermatologists Confront Suspected Drug Allergies?

Checking for and categorizing a suspected allergy allows physicians to draw up a management plan.

MedScape 15 January at 02.06 AM

Etiology Elusive in Nearly 40% Cases of Urticaria in Infants

Symptoms are most likely to resolve spontaneously, researchers said.

HealthDay 13 January at 12.12 AM

Substance Use Disorders on the Rise for Survivors of Specific Cancers

The prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.Katie F. Jones, Ph.D., from VA Boston Healthcare System, and colleagues describe cancer type-specific prevalence of SUD among adult cancer survivors in a cross-sec

HealthDay 11 January at 09.45 PM

12.8 Percent of Unique Prescribers Prescribed Topical Antifungals in 2021

In 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 million, according to research published in the Jan. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.<

HealthDay 11 January at 09.34 PM

Affordable Care Act Sees Record Number of Americans Signing Up

With only days left before open enrollment closes, the Biden administration announced Wednesday that 20 million Americans have already signed up for health insurance under the Affordable Care Act."Today, we hit a major milestone in lowering costs and ensuring all Americans have access to quality, affordable health care. With six days left to s

HealthDay 11 January at 04.48 PM

CDC: 5.7 Percent of Adults Lacked Reliable Transportation in 2022

In 2022, 5.7 percent of adults reported lacking reliable transportation for daily living, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Amanda E. Ng, Ph.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues u

MedScape 11 January at 02.53 AM

What Factors Affect Treatment Decisions in Patients With HS?

Dermatologists can empower patients to make informed, meaningful treatment choices, the authors said.

MedScape 11 January at 12.37 AM

Probiotics, Other Supplements May Benefit Patients With Acne

Myo-inositol is among the other supplements, with evidence showing they can help in patients with acne, experts said at an integrative dermatology meeting.

MedScape 10 January at 05.30 AM

Clascoterone Efficacy for Acne Increased Over Time: Analysis

Researchers integrated data from two pivotal trials and a long-term extension study.

MedScape 10 January at 05.30 AM

Clascoterone Efficacy or Acne Increased Over Time: Analysis

Researchers integrated data from two pivotal trials and a long-term extension study.

MedScape 09 January at 01.45 AM

AAAAI/ACAAI Task Force Updates AD Management Guidelines

The guidelines include 25 recommendations and address optimal use of treatments, including topical and systemic treatments, bleach baths, dietary elimination, allergen immunotherapy, and phototherapy.

MedScape 08 January at 09.57 AM

Study Identifies CV Comorbidities Linked to Dermatomyositis

The results "represent potential areas for preventative intervention," the researchers wrote.

HealthDay 08 January at 04.59 AM

Suicide Risk Increased for Some U.S. Health Care Workers

Registered nurses, health technicians, and health care support workers have an increased risk for suicide compared with non-health care workers, according to a study published in the Sept. 26 issue of the Journal of the American Medical Association.Mark Olfson, M.D., M.P.H., from Columbia University and the New York State Psychiatric

HealthDay 07 January at 04.59 AM

U.S. Safety-Net Providers Report Moral Distress in Early Pandemic

Moral distress during the first nine months of the pandemic was reported by a majority of clinicians working in U.S. safety net practices, according to a study published online Aug. 25 in BMJ Open.Donald E. Pathman, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues examined causes and levels of moral dis

HealthDay 07 January at 04.59 AM

Child Care Stress Affects Health, Work of U.S. HCWs During Pandemic

Child care stress (CCS) during the pandemic is associated with anxiety, depression, burnout, intent to reduce hours, and intent to leave among health care workers (HCWs), according to a study published online July 18 in JAMA Network Open.Elizabeth M. Harry, M.D., from the University of Colorado in Aurora, and colleagues assessed whether

HealthDay 07 January at 04.59 AM

COVID-19 Pandemic Tied to Burnout in Health Care Professionals

The COVID-19 pandemic is associated with higher burnout among health care professionals (HCPs), particularly patient-facing HCPs, according to a study published online Sept. 27 in BJPsych Open.Vikas Kapil, M.B.B.S., Ph.D., from the Queen Mary University of London, and colleagues longitudinally examined mental health in 1,574 HCPs vers

MedScape 05 January at 06.52 PM

FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum

The topical treatment is expected to be commercially available in the second half of 2024.

MedScape 05 January at 05.25 AM

Impact of Pregnancy on Rosacea Unpredictable, Study Suggests

Nearly half of study participants reported that their rosacea worsened when they were pregnant.

MedScape 05 January at 05.23 AM

Expert Highlights Biologics in the Pipeline for Eczema

Dr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors.

MedScape 04 January at 07.59 AM

US Dermatologic Drug Approvals Rose Between 2012 and 2022

Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.

HealthDay 04 January at 04.59 AM

Stress-Management Interventions May Aid Health Care Workers

Stress-management interventions may help individual health care workers over the short term, according to research published online May 12 in the Cochrane Database of Systematic Reviews.Sietske J. Tamminga, Ph.D., from the University of Amsterdam, and colleagues conducted a systematic review to evaluate the effectiveness of stress-red

MedScape 04 January at 02.06 AM

Assessing Patients With AD: Tools to Use in the Office

"It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.

MedScape 04 January at 01.09 AM

Experimental Topical Drug Shows Promise for AD, Psoriasis

In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.

HealthDay 03 January at 10.48 PM

Transgender, Gender-Diverse Individuals Report Acne-Related Stigma

Transgender and gender-diverse individuals report experiencing acne-related stigma, according to a study published online Jan. 3 in JAMA Dermatology.Sarah Gold, from the Emory University School of Medicine in Atlanta, and colleagues conducted a mixed-methods analysis at a multidisciplinary gender center using semistructured interviews

HealthDay 03 January at 04.04 PM

Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires

An increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related clinic visits in a Boston hospital system, according to a study published online Dec. 16 in Dermatology and Therapy.Kathyana P. Santiago Mangual, from Massachusetts

MedScape 03 January at 01.14 AM

5-Year Safety Data From Upadacitinib Trials Reported

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.

MedScape 03 January at 01.14 AM

5-Year Safety Data From Upadacitinib Trials Reported

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.

HealthDay 30 December at 04.59 AM

Model Predicts New Psoriatic Arthritis in People With Psoriasis

The development of psoriatic arthritis (PsA) can be predicted with reasonable accuracy for psoriasis patients, according to a study published online Aug. 9 in Arthritis & Rheumatology.Lihi Eder, M.D., Ph.D., from University of Toronto, and colleagues developed a risk prediction model (<a href="http://sharpmindtill120.x10host.co

HealthDay 29 December at 04.10 PM

Biological Agent Trials for Psoriasis Rarely Include Patient Images

Few randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online Nov. 15 in the Journal of Dermatological Treatment.Sam Polesie, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues conducted a systematic review to assess the proportio

MedScape 29 December at 11.05 AM

Conjunctivitis: How Common Is It in Patients on Dupilumab?

Adults with AD have a significant and disease severity–dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis.

HealthDay 28 December at 05.02 PM

Updated Guidelines Released for Management of Atopic Dermatitis

In updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in the Annals of Allergy, Asthma &amp; Immunology, recommendations are presented for gaining and maintaining control of atopic dermatitis (AD).Derek K. Chu, M.D., Ph.D.

HealthDay 26 December at 10.37 PM

More Than Half of U.S. Medical Interns Experience Sexual Harassment

More than half of U.S. medical interns report experiencing sexual harassment, according to a research letter published online Dec. 26 in&nbsp;JAMA Network Open.Elizabeth M. Viglianti, M.D., from the University of Michigan in Ann Arbor, and colleagues investigated possible institutional variation in experiences of sexual harassment amon

MedScape 26 December at 02.14 AM

Keeping Injectable Products in Cosmetic Dermatology Safe

The rapid increase in intradermal injections of hyaluronic acid and Botox has been accompanied by an increase in side effects.

MedScape 26 December at 01.27 AM

FDA approves topical treatment for junctional, dystrophic EB

This is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023.

MedScape 26 December at 12.26 AM

Study Links Specific Drugs to Delusions of Parasitosis Risk

Researchers conducted a case-control study of biometric and pharmaceutical data from 34 patients with delusions of parasitosis, which they compared to an age-matched control group of 53 women.

HealthDay 22 December at 10.35 PM

One in Five New Dermatology Drugs Were First in Class Over the Past Decade

From 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in&nbsp;JAMA Dermatology.Samir Kamat, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues characterized the frequency and degree of innovation of new dermatologic drugs (topic

MedScape 22 December at 12.24 AM

Paradoxical Eczema Risk Low With Biologic Psoriasis Tx

Ali Al-Janabi, MA, and associates found that 273 (1%) of approximately 25,000 drug exposures in 13,699 biologic-treated patients with psoriasis were associated with paradoxical eczema.

HealthDay 21 December at 04.51 PM

Risk for Vitiligo Increased for Transplant Recipients

Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology.Chul Hwan Bang, M.D., Ph.D., from the Catholic University of Korea in Seoul, and colleagues conducted a population-based cohort study

MedScape 21 December at 09.28 AM

Evaluating Aesthetic Concerns Among Hispanic, Latinx Women

To date, the aesthetic needs of Hispanic/Latinx patients, the second largest ethnic group in the United States, have been poorly understood.

HealthDay 21 December at 04.59 AM

Air Pollution Tied to Multimorbidity Status, Severity

Exposure to air pollution is associated with having multimorbid, multiorgan conditions, according to a study published online Dec. 2 in Frontiers in Public Health.Amy Ronaldson, Ph.D., from King’s College London, and colleagues examined associations between long-term air pollution exposure and multimorbidity status, severity, and pat

HealthDay 20 December at 11.11 PM

Osteoporosis Risk Increased With Long-Term Topical Corticosteroid Exposure

The risk for osteoporosis and major osteoporotic fracture (MOF) is increased in association with long-term exposure to topical corticosteroids (TCSs), according to a study published online Dec. 20 in the Journal of the European Academy of Dermatology and Venereology.Bing-Jun Hsieh, from the National Taiwan University Hospital in Taip

HealthDay 20 December at 10.02 PM

Burnout, Lack of Fulfillment Linked to Physician Intention to Leave

Burnout, lack of professional fulfillment, and other well-being-linked factors are associated with intention to leave (ITL) among physicians, according to a study published online Dec. 15 in JAMA Network Open.Jennifer A. Ligibel, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues describe the prevalence of burnout,

MedScape 20 December at 02.21 AM

Reducing CVD Morbidity and Mortality in Psoriasis and PsA

Only a minority of patients with psoriatic disease know about their increased risks.

HealthDay 19 December at 04.58 PM

Artificial Intelligence Models Improve Clinicians' Diagnostic Accuracy

Standard artificial intelligence (AI) models improve diagnostic accuracy, but systematically biased AI models reduce this accuracy, according to a study published in the Dec. 19 issue of the Journal of the American Medical Association.Sarah Jabbour, from the University of Michigan in Ann Arbor, and colleagues examined the impact of sys

MedScape 18 December at 04.46 PM

Roflumilast Foam Gets Nod for Seborrheic Dermatitis

Patients in the roflumilast group showed significant improvements in all secondary endpoints, including itching, scaling, and erythema.

HealthDay 18 December at 04.25 PM

Risk for Skin Cancer Increased for Patients With Lower Extremity Lymphedema

Patients with lower extremity (LE) lymphedema have an increased risk for skin cancer, especially basal cell carcinoma, according to a study published online in the November issue of Mayo Clinic Proceedings.Nimay C. Anand, M.D., from Meharry Medical College in Nashville, Tennessee, and colleagues conducted a retrospective cohort study in

MedScape 18 December at 02.18 PM

How Does Lebrikizumab Perform Across Different Subgroups?

Key eligibility criteria for both trials included adults or adolescents with a diagnosis of AD as defined by the AAD consensus criteria, for at least 1 year prior to screening.

MedScape 18 December at 02.06 PM

GVHD Raises Vitiligo Risk in Transplant Recipients

"The findings suggest that early detection and management of vitiligo lesions can be improved by estimating the likelihood of its development in transplant recipients..."

MedScape 18 December at 03.37 AM

Pilot Study Educates Barbers About Pseudofolliculitis Barbae

In the study, barbers received questionnaires before and after an educational session on the recognition, cause, prevention, and treatment of PFB, which disproportionately affects Black men.

HealthDay 15 December at 08.44 PM

Efficacy Shown for New Melanoma Therapeutic Vaccine

In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49 percent less likely to die or have their cancer return after three yea

MedScape 15 December at 05.16 PM

FDA Approves Tralokinumab for Treating Eczema in Adolescents

It is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine.

HealthDay 15 December at 12.00 AM

More Senior Physicians See Fewer Underserved Patients

Senior physicians treat fewer traditionally underserved patients than their junior colleagues within the same practices, according to a research letter published online Dec. 13 in&nbsp;JAMA Network Open.Hannah T. Neprash, Ph.D., from University of Minnesota School of Public Health in Minneapolis, and colleagues examined the associatio

MedScape 14 December at 05.00 PM

Disease Control Elusive for Many Patients on AD Therapies

A significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia."

HealthDay 14 December at 05.00 PM

Blacks More Likely to Have Disseminated Manifestations of Lyme Disease

Black patients are more likely to be diagnosed with disseminated manifestations of Lyme disease (LD) and experience longer time to appropriate treatment, according to a research letter published online Dec. 12 in JAMA Network Open.Samuel J. Starke, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues

MedScape 12 December at 05.03 PM

Acne Stigma Persists Across Social and Professional Settings

Individuals with severe acne were considered less attractive, less worthy of friendship, and less likely to be hired for a job compared with those who did not have acne.

HealthDay 12 December at 04.05 PM

ChatGPT Shows Poor Performance in Answering Drug-Related Questions

ChatGPT provided no response or incomplete or wrong answers to nearly three-quarters of drug-related questions reviewed by pharmacists, according to a study presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, held from Dec. 3 to 7 in Anaheim, California.Sara Grossman, Pharm.D., from Long Island University in

MedScape 12 December at 12.00 PM

Bimekizumab Promising for Palmoplantar Pustular Psoriasis

PPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory."

HealthDay 11 December at 04.46 PM

Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care

An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB), according to a research letter published online Dec. 6 in&nbsp;JAMA Dermatology.Xavier Rice, M.D., from the University of Texas Medical Branch in Galveston, and colleagues

MedScape 11 December at 06.13 AM

Study Eyes Melanoma Characteristics in AI/AN Population

The primary site with the highest mortality risk was the trunk.

MedScape 08 December at 05.21 PM

Tape Strips Detect Hidradenitis Suppurativa Biomarkers

"Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice."

MedScape 08 December at 04.28 PM

Combined Rituximab + Omalizumab Promising for Refractory BP

Bullous pemphigoid has high morbidity and mortality, especially in people with comorbidities common to older adults, yet no Food and Drug Administration–approved therapies for BP exist.

HealthDay 07 December at 10.56 PM

Stigmatizing Attitudes Identified Toward Individuals With Acne

Stigmatizing attitudes toward individuals with acne are observed across a range of social and professional scenarios, according to a study published online Dec. 6 in JAMA Dermatology.Ali Shields, from Drexel University College of Medicine in Philadelphia, and colleagues conducted a cross-sectional internet survey study to explore the d

HealthDay 07 December at 10.40 PM

White House Looks to Curb Big Pharma's Sky-High Drug Prices

In a push for lower drug prices, the Biden administration is warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication is too expensive. Federal law allows the government to grant patent licenses if taxpayer dollars were used in the development of inventions -- including drugs.In a <a href="ht

MedScape 07 December at 05.19 PM

Patients With hEDS Report Skin Laxity, Scarring

Follicular occlusion, mast cell disease, and eczema were common presentations among patients with hypermobile Ehlers Danlos syndrome.

HealthDay 06 December at 10.59 PM

Many Patients of Color Expect and Prepare for Unfair Health Care

Minorities often feel a deep sense of dread before doctor appointments, and some even try to dress especially well for their visit to try and ward off the possibility they will face insults or unfair care. According to a new poll conducted by hea

MedScape 06 December at 07.01 PM

How Can Dermatologists Improve Cancer Care?

Dermatologists play a key role on interdisciplinary treatment teams.

MedScape 06 December at 04.30 PM

FDA Mandates Changes to iPLEDGE Program for Isotretinoin

Isotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin.

MedScape 05 December at 06.56 PM

Hope Emerges for Patients With Rare Skin Disorder

"A new framework for thinking about and treating these diseases is emerging."

HealthDay 04 December at 10.24 PM

No Increased Suicide Risk Observed for Isotretinoin Users

Isotretinoin users do not have an increased risk for suicide or psychiatric disorders and may have a lower risk for suicide attempts, according to a review published online Nov. 29 in JAMA Dermatology.Nicole Kye Wen Tan, from the National University of Singapore School of Medicine, and colleagues clarified the absolute and relative risks

MedScape 04 December at 08.05 PM

What's New in Acne Treatment?

Advances in acne care include the use of light-based devices.

MedScape 04 December at 05.39 PM

Analysis Supports Link Between Psoriasis and OSA

Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.

MedScape 03 December at 05.25 PM

New Tools Available to Help Diagnose Skin Cancer

Emerging technologies aim to improve skin cancer diagnosis without biopsies.

MedScape 02 December at 12.19 PM

Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma

Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.

HealthDay 01 December at 05.00 PM

Ichthyosis Tied to Increased Risk of Depression, Anxiety

Ichthyosis is associated with increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the&nbsp;Journal of the American Academy of Dermatology.&nbsp;Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis and

HealthDay 01 December at 05.00 PM

Ichthyosis Tied to Increased Risk for Depression, Anxiety

Ichthyosis is associated with an increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the&nbsp;Journal of the American Academy of Dermatology.&nbsp;Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis

MedScape 01 December at 10.49 AM

Novel Subcutaneous Biologics Show Promise in AD

Patients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials.

MedScape 01 December at 08.10 AM

Meta-Analysis: Suicide Risk Not Increased With Isotretinoin

In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.

MedScape 30 November at 02.31 PM

Dietary Supplements May Play a Role in Managing Vitiligo

Dietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy.

MedScape 30 November at 01.34 PM

Pilonidal Disease: Study Finds Laser Hair Removal Beneficial

The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease.

HealthDay 29 November at 04.37 PM

AI Accurate in Diagnosing Suspicious Skin Lesions

A mobile phone-powered artificial intelligence (AI) technology is effective for diagnosing suspicious skin lesions, according to a study published in the October issue of&nbsp;The Lancet Digital Health.Scott W. Menzies, Ph.D., from the University of Sydney, and colleagues compared the accuracy of AI algorithms and clinicians for the

MedScape 28 November at 07.24 PM

Tapinarof Effective for AD in Patients as Young as 2 years

Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.

MedScape 28 November at 05.52 PM

Nail Psoriasis in Black Patients Often Overlooked

Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.

MedScape 28 November at 02.18 PM

HS: Positive Results Reported With Anti-IL17A/F Therapies

One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.

MedScape 28 November at 01.56 PM

At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib

With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'

MedScape 23 November at 09.06 AM

Parent Concerns a Factor When Treating Patients With AD

For a parent whose child has an inflammatory skin disease, pigmentation changes, rather than inflammation, might be the reason that he or she brought the child to the clinician.

HealthDay 22 November at 10.51 PM

Incidence of Local-Stage Cancers Decreased From 2019 to 2022

From 2019 to 2020, the incidence of local-stage disease decreased significantly for 19 of 22 cancer types compared with stable year-over-year changes pre-COVID-19, according to a study published online Nov. 16 in the International Journal of Cancer.Elizabeth J. Schafer, M.P.H., from the American Cancer Society in Atlanta, and colleag

MedScape 22 November at 11.08 AM

Questionnaire Measures Patient Satisfaction With Acne Tx

A dermatology-specific questionnaire assessed three aspects of treatment in patients with acne.

MedScape 20 November at 06.20 AM

Lebrikizumab Gets the Nod in the EU for Atopic Dermatitis

Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.

MedScape 17 November at 05.48 AM

New Consensus Guide on Rare Drug Hypersensitivity Reaction

Experts provided parameters to help clinicians, but they acknowledged the limited evidence base for drug reaction with eosinophilia and systemic symptoms.

HealthDay 16 November at 05.00 PM

Recommendations Developed for Atopic Dermatitis Therapies

In updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are presented for use of phototherapy and systemic therapies for atopic dermatitis (AD) and include strong endorsements of monoclonal antibodies and Janus kinase inhib

MedScape 15 November at 05.53 AM

Isothiazolinone Allergy Common, Often to Multiple Allergens

Many people in North America appear to be allergic to one or more of a family of preservatives used in personal care products and household cleaners implicated in the global spread of allergic contact dermatitis.

MedScape 14 November at 06.21 PM

LE Lymphedema Associated With Greater Skin Cancer Risk

In the retrospective study, patients with lower extremity lymphedema were at an almost twofold greater risk for skin cancer compared with matched controls.

HealthDay 14 November at 04.15 PM

Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria

For patients with chronic spontaneous urticaria (CSU), acupuncture produces a greater improvement in the Weekly Urticaria Activity Score (UAS7), although the difference is not clinically significant, according to a study published online Nov. 14 in the Annals of Internal Medicine.Hui Zheng, M.D., Ph.D., from the Chengdu University of T

MedScape 13 November at 08.47 PM

AAD Updates Guidelines for Managing AD

The guidelines cover approved and off-label uses of systemic therapies and phototherapy, including new treatments that have become available since the last guidelines were published in 2014.

MedScape 13 November at 05.00 PM

Dermatopathologists Make More Higher-Grade Dx of Lesions

The findings &quot;could in part play a role in the rising incidence of early-stage melanoma with low risk of progression or patient morbidity, thereby contributing to increasing rates of overdiagnosis.&quot;

HealthDay 13 November at 04.54 PM

ACAAI: Parents, Patients Offer Theories on Causes/Origins of Food Allergies

Parents and adult patients with food allergy (FA) believe that factors such as diet, genetics, family history, and infection are associated with FA development, according to a study presented at the annual meeting of the American College of Allergy, Asthma &amp; Immunology, held from Nov. 9 to 13 in Anaheim, California.Rachelle Liu, from the Nor

MedScape 13 November at 02.15 PM

Prurigo Nodularis Dx Delay in Skin Types Gains Significance

Patients with darker skin types tend to have larger nodules that might vary in shape relative to lighter skin types, according to Shawn Kwatra, MD.

MedScape 13 November at 12.36 PM

Palmoplantar Pustulosis: Treatment Challenges

When it comes to pustular disease localized to the hands and feet, treatment options have only modest efficacy, according to speakers at the annual National Psoriasis Foundation research symposium.

MedScape 09 November at 12.50 PM

Incipient Ulceration May Affect Prognosis in Primary Melanoma

Assigning a lower-risk pathologic T stage to such melanomas may not be appropriate, the study authors conclude.

MedScape 09 November at 09.27 AM

Actinic Keratoses May Predict Skin Cancers in Older Adults

A retrospective cohort study showed increased absolute and relative risks for skin cancers up to 5 years after an AK diagnosis.

MedScape 08 November at 05.43 PM

Sharps Injuries Are Common Among Mohs Surgeons, Survey Finds

Among respondents who sustained a sharps injury, 44.1% did not report them.

MedScape 08 November at 05.13 PM

BDD: Diagnosis Guidelines to be Published in Europe

The guidelines support uniform screening for BDD in all patients prior to cosmetic procedures.

MedScape 08 November at 04.48 PM

Teasing Apart Multiple Biologic Failure in Psoriasis, PsA

'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'

MedScape 08 November at 01.50 PM

Vitiligo: 'Impressive' Results for Povorcitinib, Baricitinib

Substantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy.

MedScape 06 November at 04.02 PM

What Can Clinicians Do to Treat Patients With Vitiligo?

Dismissing the idea that nothing can be done for these patients, a dermatologist reviews the current and emerging therapeutic options.

HealthDay 03 November at 11.00 PM

Critics Slam Updated Infection Control Recommendations for Hospitals

Advisors to the U.S. Centers for Disease Control and Prevention are expected to approve new draft guidelines for hospital infection control this week, the first update since 2007.But health care workers worry whether the guidelines, which suggest that surgical masks are as good as N-95 masks at preventing the spread of respiratory infections duri

MedScape 03 November at 04.43 PM

Topical Ivermectin Study Sheds Light on Dysbiosis in Rosacea

Study findings show that ivermectin reduces the density of Demodex folliculorum in rosacea lesions, but the skin microbiome takes time to recover.

HealthDay 03 November at 03.28 PM

AI Getting Better at Detecting Skin Cancer

Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Oct. 11 to 14 in Berlin.Kashini Andrew, M.B.B.S., from the University Hospitals Birmingham NHS Foundation Trust in the United Kingdom, and colleagues

MedScape 03 November at 10.12 AM

Ready to Start Engaging on Social Media?

In the opinion of Swati Kannan, MD, deciding whether or not to establish a presence on social media starts with a gut-check about your intentions.

HealthDay 02 November at 11.00 PM

FDA Approves Wezlana for Multiple Inflammatory Diseases

The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.&nbsp;The approval includes indications for adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic a

HealthDay 02 November at 03.40 PM

Skin Diseases Pose a Psychosocial Burden

Skin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the&nbsp;Journal of the European Academy of Dermatology and Venereology.Paolo Gisondi, M.D., from the University of Verona in Italy, and colleagues evaluated the burden of the most common dermatological diseases

HealthDay 01 November at 10.10 PM

Interventions to Redesign Patient Care Do Not Improve Outcomes

Interventions to redesign care for hospitalized patients are not associated with improved patient outcomes, according to a study published online Oct. 31 in the Annals of Internal Medicine.Kevin J. O'Leary, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the effect of intervention

HealthDay 01 November at 06.54 PM

More Than Half of U.S. Adults Use Internet to Look for Health, Medical Information

More than half of adults used the internet to look for health or medical information during July to December 2022, with higher prevalence among women than men, according to an October data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Xun Wang and Robin A. Cohen, Ph.D., from the Na

HealthDay 01 November at 03.16 PM

AAP: Children Most Likely to Present to ED With Burns From Hair Styling Tools

Children younger than 10 are most likely to present to the emergency department with burn injuries sustained from hair styling tools, especially hair curlers and curling irons, according to a study presented at the annual meeting of the American Academy of Pediatrics, held from Oct. 20 to 24 in Washington, D.C.Brandon L. Rozanski, M.D., from T

MedScape 01 November at 02.29 PM

CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors

'There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population,' the study authors wrote.

MedScape 01 November at 10.42 AM

Study Finds Ruxolitinib Effective, Safe for Children With AD

There were no significant safety signals in the younger pediatric population, and 'no treatment-emergent adverse events suggestive of systemic JAK inhibition,' Dr Lawrence Eichenfield said.

MedScape 31 October at 08.27 PM

FDA Approves Secukinumab for Adults With HS

This marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor.

MedScape 31 October at 06.37 PM

¬¬Study Spotlights Features of Infantile Hemangioma Subset

Detailed reports on this patient population are sparse and limited to case reports and small case series.

MedScape 31 October at 06.37 PM

Study Spotlights Features of Infantile Hemangioma Subset

Detailed reports on this patient population are sparse and limited to case reports and small case series.

MedScape 30 October at 04.59 PM

Dupilumab-Associated Lymphoid Reactions Require Caution

Retrospective study identifies potential for misdiagnosed mycosis fungoides and for dupilumab to fuel cutaneous lymphoid reactions that mimic mycosis fungoides in patients with atopic dermatitis.

HealthDay 30 October at 03.58 PM

Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab

For adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to a study published online Oct. 18 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleag

HealthDay 27 October at 10.29 PM

Teens With Atopic Dermatitis More Likely to Experience Bullying

Adolescents with atopic dermatitis have higher odds of being bullied at higher frequency after adjustment for demographics, atopic comorbidities

MedScape 27 October at 05.50 PM

Multicenter HS Study Expanding to More Clinical Sites

Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.

MedScape 27 October at 04.43 PM

Acne: Study Evaluates the Evidence for Nutraceuticals

Despite the many acne treatments available, 'patients may be interested in natural and complementary therapies as either an adjunctive or an alternative to prescription medications,' the authors said.

HealthDay 26 October at 09.17 PM

Affording Health Care Now a Struggle for Half of Americans: Poll

More than half delayed or skipped care because of concerns about costs

HealthDay 26 October at 03.43 PM

Nemolizumab Improves Symptoms in Prurigo Nodularis

Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response

MedScape 25 October at 02.15 PM

Nemolizumab Promise for Prurigo Nodularis Continues

Results from OLYMPIA 1 provide further support for nemolizumab as a potential first-in-class prurigo nodularis treatment; in another study, a JAK inhibitor was beneficial in patients with PN.

MedScape 25 October at 01.05 PM

GW Teledermatology Model Expands to Four Underserved Areas

Four institutions will receive grants to implement the model, which involved partnering with a local organization to provide an entry point for individuals in areas with limited access to medical care.

MedScape 25 October at 12.11 PM

FDA Approves Triple Combination Topical Treatment for Acne

The product combines an antibiotic, a retinoid, and an antibacterial in a gel formulation.

MedScape 25 October at 11.00 AM

Bullying More Prevalent Among Adolescents With AD

Data were collected from adult caregivers of more than 3200 adolescents in the United States.

MedScape 25 October at 06.24 AM

Shared Decision-Making Low in Patients With Psoriasis

The study findings underscore the importance of enhancing clinician-patient communication, the authors say.

MedScape 24 October at 01.15 PM

Strategy Shows Promise for Psoriasis Remission in Early Study

The study is investigating whether high-dose IL-23 inhibition can target resident memory T cells and thereby induce long-term remission.

MedScape 24 October at 12.46 PM

Oleogel-S10 Reduces Daily Dressing Need in EB Study

Oleogel-S10 reduced the need for daily dressing changes compared with a control gel in patients with epidermolysis bullosa, according to a further analysis of data from the phase 3 EASE study.

MedScape 23 October at 01.47 PM

FDA Calls for More Data on Dupilumab for CSU Indication

In a letter, the FDA stated that additional efficacy data are required to support an approval for chronic spontaneous urticaria (CSU), according to the manufacturers of dupilumab.

MedScape 20 October at 01.01 PM

AI Can Flag Skin Cancer With Near-Perfect Accuracy

Artificial intelligence could help dermatologists catch skin cancer faster and triage patients.

MedScape 19 October at 01.29 PM

Review Estimates Acne Risk With JAK Inhibitor Therapy

A systematic review and meta-analysis with more than 10,000 individuals showed a significant increase in acne associated with JAK inhibitors.

MedScape 18 October at 01.44 PM

FDA Approves Bimekizumab for Plaque Psoriasis in Adults

Bimekizumab is the first IL-17A and IL-17F inhibitor approved by the FDA for adults with psoriasis.

MedScape 18 October at 12.11 PM

Recombinant IL-2 Shows Potential in Atopic Dermatitis

&quot;This is the first study to demonstrate the therapeutic potential of rezpegaldesleukin,&quot; said Jonathan Silverberg, MD, PhD, MPH, who presented results of a phase 1b study.

MedScape 13 October at 01.48 PM

Once-Weekly Topical Therapy Shows Promise for Acne

Researchers say the novel once-weekly application could improve patient adherence.

MedScape 13 October at 01.31 PM

Patients With Psoriasis Lose Weight With Roflumilast: Study

Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.

MedScape 12 October at 04.23 PM

Novel Triple Threat Approach to Acne Beats Placebo

A topical therapy that combines three acne medications applied once a day showed efficacy superior to a vehicle in two phase 3 studies of children and adults with moderate to severe acne.

MedScape 12 October at 12.34 PM

Topical Botanical Drug Coacillium Curbs Childhood Alopecia

Greater improvement in Severity of Alopecia Tool (SALT) scores at 24 weeks were seen with coacillium vs placebo, which lasted after treatment stopped.

MedScape 11 October at 03.48 PM

Analysis Spotlights Economic Burden of Vitiligo in the US

Determining medical costs will help identify the main expenditure predictors and spending patterns, according to the authors.

MedScape 11 October at 11.01 AM

Imaging Test Helps Detect Craniofacial Morphea Progression

Assessment of images also showed strong interrater reliability in patients with Fitzpatrick skin types IV to VI.

MedScape 09 October at 03.27 PM

Palmoplantar Psoriasis More Common Among Black Children

The prevalence of nail, palm, and sole involvement was highest among Black children with psoriasis compared with children of other ethnicities.

MedScape 06 October at 03.20 PM

FDA OKs Topical Roflumilast for Psoriasis in Kids Aged 6-11

This marks an expanded indication for the drug, which was first approved for the same indication in July 2022 for individuals aged 12 and older.

MedScape 04 October at 01.50 PM

Study Finds Higher Prevalence of ACD Among Children With AD

More children with AD should be evaluated for ACD and undergo patch testing, study authors say.

MedScape 04 October at 10.21 AM

Spironolactone Effective Treatment for Women With HS, Study

The anti-androgenic agent is used to treat HS in women, but there is a paucity of data on its efficacy and whether certain patient characteristics influence response.

MedScape 02 October at 04.24 PM

FDA Issues Letter Regarding Lebrikizumab Review for AD

The FDA has issued a complete response letter regarding lebrikizumab, an investigational biologic for the treatment of adult and adolescent patients with moderate to severe atopic dermatitis.

MedScape 28 September at 08.57 PM

Study Finds IBD Risk Higher in Children, Adults with AD

Children and adults with atopic dermatitis may be at increased risk for inflammatory bowel disease, researchers report.

MedScape 28 September at 06.01 PM

A Glimpse at Devices Designed to Tackle Cellulite

While mechanical subcision of fat septa with a scalpel or a large bore needle is a tried-and-true treatment for cellulite, other technologies have emerged as alternatives.

MedScape 28 September at 05.31 PM

'Old School’ Laser Rx Remains Effective Rejuvenation Option

Drawbacks to fully ablative laser resurfacing include significant downtime and extensive wound care, &quot;so it’s not for everybody,&quot; says Arisa E. Ortiz, MD.

MedScape 25 September at 05.07 PM

Study Spotlights Paucity of Black Dermatologists in Academia

Black faculty comprise just 18.7% of active Black dermatologists in the United States, according to a 2022 report from the Association of American Medical Colleges.

MedScape 25 September at 02.11 PM

Thread Lifts an Option for Noninvasive Facial Tightening

Downtime with thread lifts is minimal, but results are 'subtle' and 'not long lasting.'

MedScape 21 September at 05.48 PM

Does the Number of Primary Melanomas Affect Survival?

Detecting melanoma at an early stage remains the biggest influence on mortality after one or more melanomas are diagnosed, according to investigators.

MedScape 21 September at 11.54 AM

Pain Evaluated as Pyoderma Gangrenosum Outcome Measure

According to researchers, this is the first minimal important difference (which can help determine whether patients are responding to treatment) that has been calculated for an ulcerative skin condition.

MedScape 20 September at 06.00 PM

Most Adults With Alopecia Areata Untreated 1 Year After Dx

In the study, two-thirds of newly diagnosed patients had received at least one treatment within the first year of diagnosis.

MedScape 20 September at 11.00 AM

Study Confirms Psoriasis Linked to Higher Heart Disease Risk

To date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction.

MedScape 20 September at 01.00 AM

Study Confirms Psoriasis Linked to Higher Heart Disease Risk

To date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction.

MedScape 19 September at 04.46 PM

European Commission Approves Ritlecitinib for Severe AA

This makes ritlecitinib the first medicine authorized by the EC to treat individuals with severe alopecia areata as young as 12 years of age.

MedScape 19 September at 02.55 PM

Combining Lasers to Maximize Results, Patient Satisfaction

The order of device use matters, according to Dr. Mathew Avram.

MedScape 18 September at 01.57 PM

When Treating Scars, ‘Rehabilitation’ is the Goal

&quot;When you treat a scar, you treat the features of the scar that make it stand out.&quot;

MedScape 15 September at 04.34 PM

CHMP Recommends Marketing of Biologic for Atopic Dermatitis

Lebrikizumab is a monoclonal antibody that binds to cytokine IL-13, which has been implicated in driving the type-2 inflammatory loop in the skin, leading to skin barrier dysfunction.

MedScape 14 September at 12.43 PM

High Rate of Subsequent Cancers in Merkel Cell Carcinoma

In this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018.

MedScape 12 September at 04.28 PM

Company Submits Supplemental NDA for Topical AD Treatment

Submission is based on positive results from two phase 3, vehicle-controlled trials in patients ages 6 and older with mild to moderate AD.

MedScape 11 September at 04.39 PM

Can Skin Bleaching Lead to Cancer?

The use of skin-lightening products is associated with a wide range of complications. Is squamous cell carcinoma one of them?

MedScape 07 September at 12.51 PM

Expert Reviews Use of Noninvasive Fat Removal Procedures

CoolSculpting freezes excess fat to remove it from stubborn areas via panniculitis. It accounts for about 72% of the noninvasive fat removal treatments performed in the US, according to an expert.

MedScape 05 September at 01.51 PM

Going Into Solo Practice? An Expert Shares Tips

Catherine M. DiGiorgio, MD, MS, found herself at a crossroads: stay and work for a large corporation or open a solo practice?

MedScape 05 September at 10.10 AM

'Barbie Botox' Goes Viral but Doctors Inject Caution

The viral trend of 'Barbie Botox' has women as young as in their 20s rush for toxin-based procedures to mimic the looks of the movie's lead actress Margot Robbie.

MedScape 31 August at 05.25 PM

Tralokinumab Safe, Effective in Older Pop With AD: Analysis

The findings are important for the older patient population who &quot;typically face unique treatment challenges,&quot; the authors write.

MedScape 29 August at 04.50 PM

FDA to Step Up Oversight of Cosmetics, Assess PFAS

A 2022 law expanded the FDA's authority to regulate makeup, and it also set a 3-year deadline for a report on potential risk of PFAS, known as 'forever chemicals,' in cosmetics.